18699-02-0 | Actarit

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$14.00	$10.00
5g	97%	in stock	$29.00	$21.00
10g	97%	in stock	$55.00	$38.00
25g	97%	in stock	$73.00	$51.00
100g	97%	in stock	$201.00	$141.00
500g	97%	in stock	$572.00	$400.00

Description

• Catalog Number: AI41993
• Chemical Name: Actarit
• CAS Number: 18699-02-0
• Molecular Formula: C10H11NO3
• Molecular Weight: 193.19924000000003
• MDL Number: MFCD00196165
• SMILES: OC(=O)Cc1ccc(cc1)NC(=O)C
• NSC Number: 170317

Computed Properties

• Complexity: 219
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• XLogP3: 0.8

Literature

• Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.

  Drug metabolism and disposition: the biological fate of chemicals 20120401

• Risk of orthopedic surgical site infections in patients with rheumatoid arthritis treated with antitumor necrosis factor alfa therapy.

  International journal of rheumatology 20120101

• Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.

  Bioinformatics (Oxford, England) 20100615

• Determination of actarit from human plasma for bioequivalence studies.

  Indian journal of pharmaceutical sciences 20100101

• Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.

  Journal of pharmaceutical sciences 20091101

• A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis.

  Modern rheumatology 20090801

• Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.

  International journal of pharmaceutics 20080320

• Photosensitizing properties of Actarit, an antirheumatic drug.

  Arzneimittel-Forschung 20080101

• Inhibitory effect of some acetyl esters and acetamides on glycation of the histone H1.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20080101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.

  Modern rheumatology 20060101

• The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.

  Rheumatology international 20051001

• [Examination of the escape phenomenon in disease modifying antirheumatic drugs].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20050301

• [A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy].

  Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 20040601

• Glucosides of Chaenomeles speciosa remit rat adjuvant arthritis by inhibiting synoviocyte activities.

  Acta pharmacologica Sinica 20031101

• [Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].

  Ryumachi. [Rheumatism] 20010601